Aditxt, Inc. Notes Payable, Current
Aditxt, Inc. (ADTX) had Notes Payable, Current of $3.31 million as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:NotesPayableCurrent · last filed 2026-05-20
- 2026-03-31: Notes Payable, Current $3.31M.
- 2025-12-31: Notes Payable, Current $1.86M.
- 2025-09-30: Notes Payable, Current $4.70M.
- 2025-06-30: Notes Payable, Current $4.53M.
| Period end | Notes Payable, Current |
|---|---|
| 2026-03-31 | $3.31M 10-Q · filed 2026-05-20 |
| 2025-12-31 | $1.86M 10-Q · filed 2026-05-20 |
| 2025-09-30 | $4.70M 10-Q · filed 2025-11-18 |
| 2025-06-30 | $4.53M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.96M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $5.54M 10-K · filed 2026-03-31 |
| 2024-09-30 | $8.37M 10-Q · filed 2024-11-18 |
| 2024-06-30 | $5.95M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $5.68M 10-Q · filed 2024-05-20 |
| 2023-12-31 | $15.65M 10-K · filed 2025-03-31 |
| 2023-06-30 | $300.00K 10-Q · filed 2023-08-14 |
| 2022-09-30 | $80.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $465.85K 10-Q · filed 2022-08-15 |
| 2020-06-30 | $830.60K 10-Q · filed 2020-08-13 |
| 2019-12-31 | $155.60K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |